Predictors of Hypofibrinogenemia in Severe Trauma
NCT03020849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1038
Last updated 2017-07-28
Summary
In this retrospective and prospective study, the aim is to determine a score for predicting a fibrinogen \<1.5g/L (corresponding to European threshold of Directors recommendations of fibrinogen concentrates)
Conditions
- Severe Trauma
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- France
Study Locations
More Related Trials
-
Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage
NCT02091479 ·Status: TERMINATED ·Phase: PHASE3
-
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.
NCT06705829 ·Status: RECRUITING
-
Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients
NCT05301829 ·Status: UNKNOWN
-
Predicting the Risk of Venous Thromboembolism in Critically Ill Patients
NCT05498142 ·Status: UNKNOWN
-
Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration
NCT05503498 ·Status: COMPLETED
-
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
NCT02884934 ·Status: COMPLETED
-
Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System
NCT05422157 ·Status: COMPLETED
-
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage
NCT06974396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Determination of Residual Anticoagulatory Effects of Fondaparinux
NCT01101256 ·Status: UNKNOWN
-
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
NCT01264458 ·Status: COMPLETED
-
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia
NCT01727401 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetics of Enoxaparin in Intensive Care Patients
NCT02095509 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol
NCT02848612 ·Status: COMPLETED
-
Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics
NCT01210755 ·Status: COMPLETED ·Phase: PHASE4
-
Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs
NCT03634124 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor
NCT07342127 ·Status: COMPLETED
-
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
NCT00362492 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
NCT00531843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Prevention of Venous Thromboembolism Disease in Emergency Departments
NCT01212393 ·Status: COMPLETED
-
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
NCT00311753 ·Status: COMPLETED ·Phase: PHASE3
-
Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period
NCT04883385 ·Status: COMPLETED
-
Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study
NCT02384135 ·Status: UNKNOWN ·Phase: NA
-
New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study "FIT GENETIQUE".
NCT02841085 ·Status: COMPLETED
-
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
NCT00555438 ·Status: COMPLETED ·Phase: PHASE4